CPA Strategic Plan
A Further Step 2014 – 2017
Foreword by Raymond Anderson
(CPA President 2011-2017)
In 12-18 months between 2013 the Executive Committee of CPA, in recognition of the importance and value of CPA to individuals, organisations and Governments in delivering better health care and, in particular, improved medicines management, has developed a new strategy. This strategy is designed to enable the organisation to better respond to the challenges of the 21st century, to build its membership and offer a greater level of support to its members, particularly to those in the developing world; also to strengthen and extend its collaborative networks in the interests of synergistic working.
This document is an elaboration on our strategy to give further rationale and definition to the work on which we have now embarked. It sets out four strategic themes: organisational development, governance and sustainability, organisation promotion and membership, education and training provision, and advocacy and representation. Already we have made some good progress but the success of the strategy will not be simply what we can do from the office but what can be done with collaborative support from our member organisations and individuals.
The implementation of the strategy will, of course, demand resources, for example, to allow for investment in promoting the organisation through its website, in developing resource and training materials to meet members’ CPD requirements, building collaboration with partner organisations and to support countries in the development of pharmaceutical policy and strategic planning. Our membership fees coupled with a generous two year grant from the Royal Pharmaceutical Society will contribute to these developments but with further grant aid from external organisations and individuals I believe we can make an even more significant contribution to pharmaceutical development in our member countries.
So do join me and my Executive Committee colleagues as we seek to progress this work. I am confident that in its implementation it will significantly contribute to pharmaceutical development across the Commonwealth, the individual status of pharmacists as health care providers and, most importantly, the health and wellbeing of the communities we serve.